RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 107 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $761,000 | -75.4% | 30,567 | -79.8% | 0.00% | -100.0% |
| Q2 2021 | $3,090,000 | +5730.2% | 151,446 | +6046.3% | 0.00% | – |
| Q1 2021 | $53,000 | -75.0% | 2,464 | -61.6% | 0.00% | – |
| Q4 2020 | $212,000 | +430.0% | 6,418 | +263.6% | 0.00% | – |
| Q3 2020 | $40,000 | -32.2% | 1,765 | -34.4% | 0.00% | – |
| Q2 2020 | $59,000 | -30.6% | 2,689 | -27.3% | 0.00% | – |
| Q4 2019 | $85,000 | +93.2% | 3,697 | +83.5% | 0.00% | – |
| Q3 2019 | $44,000 | +2.3% | 2,015 | +3.7% | 0.00% | – |
| Q2 2019 | $43,000 | – | 1,943 | +194200.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 216 | +105.7% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 105 | +20.7% | 0.00% | – |
| Q2 2018 | $3,000 | – | 87 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |